🔗 Share this article

An underground market for unlicensed weight-loss drugs is propelled by TikTok fitness influencers and vendors on messaging platforms, according to recent findings.

Investigational Treatment Gaining Popularity Online

Retatrutide, which is still in clinical trials, is being advertised by social media influencers for its supposed fat-burning properties. Followers are encouraged to contact these profiles directly for source information, while also receiving promotional offers.

Thriving Trade on Messaging Platforms

Separately, a flourishing trade exists on Telegram, where groups with thousands of participants share “before and after” images, injection guides and claims of rapid British shipping. Sellers promote the drug there before redirecting buyers to WhatsApp for purchases.

Learning About Retatrutide

Retatrutide is an investigational injectable created by American pharmaceutical company Eli Lilly. The drug affects three intestinal hormones – GLP-1, GIP and glucagon. Early trials indicate it could help individuals lose up to 25% of their body weight. Nicknamed the “triple G”, the drug is being hailed online as the successor to Ozempic.

Healthcare Professionals Voice Worries

Nevertheless, doctors and pharmacists have warned that the sale of what is still an unlicensed drug in the United Kingdom is a cause for concern and could lead to individuals administering products of uncertain source.

Several professionals said the popularity for the experimental drug could be linked to the increasing cost of licensed slimming products such as Mounjaro.

Regulatory Position and Enforcement

Marketing the unapproved drug on social media or messaging apps is prohibited in the United Kingdom, as it is an unlicensed medication that must not be promoted or supplied for human use under the British medical regulations.

Several influencers attempt to circumvent the rules by referring to the drug as a “research chemical” or describing it as “not for human consumption”. The substance is not a restricted substance, but promotion and supply can still violate medicines, marketing, and consumer regulations, risking penalties, prosecution or imprisonment.

Platform Reaction and Material Elimination

According to the social media company, the platform has removed problematic material and banned related hashtags and query recommendations. The organization said it was dedicated to maintaining the service safe and investing in strengthening enforcement strategies.

Online Marketplace Operations

Research also discovered communities with up to nine thousand participants marketing retatrutide using Telegram's integrated search feature, which functions like a online catalog. Typing “retatrutide” immediately displays groups with thousands of users, filled with photos of weight loss, positive reviews and detailed guides for mixing or injecting at home.

After minutes of joining one group, a seller posted contact information, where most purchases take place. The vendor sent an guidebook and promised shipping within two days. When asked whether the substance was genuine, one seller responded: “You can’t be sure.” Another shared a image of a supposed testing documentation. Not one inquired about weight, health issues or past usage.

Product Information and Pricing

Within these communities, messages display black plastic packages with Royal Mail stickers, stating to contain new batches. One message read: “It took eight of us to load them this morning.”

Buyers can select between dry substance containers, prepared at residence with purified liquid, or pre-filled pens usually priced at 160 pounds for 20mg. When asked how much time a injector should last, sellers give contradictory responses varying between a several days to “depends on your body”.

Service Moderation and Security Measures

A representative for the messaging service stated it actively moderated dangerous content on its service including content that promoted the “misuse of controlled medications”. The company added that it removed “millions of pieces of harmful content each day”.

Healthcare Expert Warnings

“Individuals are injecting substances they cannot confirm. Even if the science behind this drug is sound, these digital versions may not contain what they claim,” stated a pharmacy expert, the director of pharmaceutical services at a pharmacy service.

Dr Crystal Wyllie of Asda Online Doctor linked the surge in interest to recent cost increases for approved slimming drugs such as Mounjaro. “With prices increasing, individuals are using social media. But counterfeit treatments are highly dangerous. You can’t be certain what’s contained or whether the environment they were made in was clean,” she said.

Her team has already seen patients injured by self-injection from unconfirmed sources. “We recognize the frustration, but buying from messaging apps or communication platforms is taking chances with your health,” said the doctor. “These substances could be contaminated or improperly measured.”

Manufacturer Position

A representative from Eli Lilly stated the substance was in phase 3 research studies and had not been evaluated or approved by any regulatory agency anywhere in the world. “Therefore at this point no one can market [it] for human use,” they said, adding that any item “misleadingly claiming itself as a company experimental substance not yet approved … may subject users to possibly serious health risks”.